Introduction

Arul M. Chinnaiyan, M.D., Ph.D.
University of Michigan Medical School
Therapeutic Targeting of SPINK1-Positive Prostate Cancer

Scott Dehm, Ph.D.
University of Minnesota
AR Intragenic Rearrangement and Altered mRNA Splicing in Castration-Resistant Prostate Cancer

Michael R. Freeman, Ph.D.
Harvard Medical School
Cholesterol and Prostate Cancer

Eugene D. Kwon, M.D.
Mayo Clinic
Checkpoint Blockade for Prostate Cancer Immunotherapy

James L. Mohler, M.D.
Roswell Park Cancer Institute
Intracrine Metabolism of Testicular Androgens by Castration-Recurrent Prostate Cancer

Muneesh Tewari, M.D., Ph.D.
Fred Hutchinson Cancer Research Center
Circulating MicroRNAs and Prostate Cancer

Jianfeng Xu, M.D., Ph.D.
Wake Forest University School of Medicine
Clinical Validity and Utility of Inherited Genetic Markers in Prostate Cancer Risk Prediction